Home › Funds › J. Safra Sarasin Holding AG › GILD

J. Safra Sarasin Holding AG position in GILD

GILEAD SCIENCES INC · Health Care

J. Safra Sarasin Holding AG reported holding 709,209 shares of GILD (GILEAD SCIENCES INC) in its Q3 2026 13F filing — a position valued at US$100.1M, representing 1.42% of its reported portfolio and ranking #13 among its reported holdings. J. Safra Sarasin Holding AG has disclosed GILD holdings in 10 of the last 10 reported quarters, going back to Q2 2024.

Latest position (Q3 2026)709.21K sh
Reported value held$100.08M
Portfolio Weight1.42%
First reportedQ2 2024
Last changeAdd
Updated2026-10-26

Last updated: 2026-10-26 · Source: SEC EDGAR Form 13F-HR

How J. Safra Sarasin Holding AG's GILD position evolved

J. Safra Sarasin Holding AG first disclosed a stake in GILD in Q2 2024 at 838,143 shares (US$57.5M). The position peaked in Q4 2025 at 819,403 shares, worth US$100.6M. Across 10 filings, J. Safra Sarasin Holding AG increased the stake 2 time(s), trimmed it 7 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 709,209 shares valued at US$100.1M — an increase of 18,432 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q2 2024 838.14K $57.49M New
Q3 2024 822.73K $68.98M Reduce
Q4 2024 802.20K $74.10M Reduce
Q1 2025 779.05K $87.29M Reduce
Q2 2025 730.53K $80.99M Reduce
Q3 2025 897.79K $99.66M Add
Q4 2025 819.40K $100.57M Reduce
Q1 2026 721.26K $100.52M Reduce
Q2 2026 690.78K $94.84M Reduce
Q3 2026 709.21K $100.08M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About GILD and 13F data

GILD (GILEAD SCIENCES INC) is a Health Care company. 35 other funds we track also report a position in GILD — the largest reported positions include Fidelity Management & Research (FMR) (US$8.45B), Capital World Investors (US$5.18B), Capital World Investors (US$5.18B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding GILD

All GILD fund holders →

FAQ

How long has J. Safra Sarasin Holding AG held GILD?

J. Safra Sarasin Holding AG has disclosed GILD holdings in 10 of the last 10 reported quarters, going back to Q2 2024.

What is J. Safra Sarasin Holding AG's current position in GILD?

As of Q3 2026, J. Safra Sarasin Holding AG holds 709.21K shares of GILD (GILEAD SCIENCES INC), valued at $100.08M, representing 1.42% of its reported portfolio and ranking #13.

Has J. Safra Sarasin Holding AG been buying or selling GILD?

In the latest 13F filing (Q3 2026), J. Safra Sarasin Holding AG increased its position in GILD. The position peaked in Q4 2025 at 819.40K shares.

Which other funds hold GILD?

Other major institutional holders of GILD include Fidelity Management & Research (FMR), Capital World Investors, Capital World Investors, among 35 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.